BRIEF published on 12/17/2025 at 07:35, 10 months 18 days ago Sanofi Releases Q4 2025 Aide Mémoire Sanofi Financial Modeling Aide Mémoire Q4 2025 Forward-Looking
BRIEF published on 12/17/2025 at 07:35, 10 months 18 days ago Sanofi publishes the document "Q4 2025 Quick Reference Guide" Financial Results Investors Sanofi Q4 2025 Modeling
BRIEF published on 12/17/2025 at 07:35, 10 months 18 days ago Sanofi publie le document « Q4 2025 Aide mémoire » Résultats Financiers Investisseurs Sanofi Modélisation Q4 2025
PRESS RELEASE published on 12/17/2025 at 07:30, 10 months 18 days ago Press release: Availability of the Q4 2025 Aide memoire Sanofi announces availability of Q4 2025 Aide memoire on the company's website for financial modeling purposes. Q4 2025 results to be published on January 29, 2026 Sanofi Results Aide Mémoire Financial Modelling Q4 2025
PRESS RELEASE published on 12/17/2025 at 07:30, 10 months 18 days ago Communiqué de presse : Mise en ligne du document «Q4 2025 Aide mémoire » Sanofi annonce la mise en ligne du document 'Q4 2025 Aide mémoire' pour assister la communauté financière dans la modélisation des résultats trimestriels Communication Financière Résultats Trimestriels Sanofi Document Q4 2025
BRIEF published on 12/15/2025 at 07:10, 10 months 20 days ago Sanofi: PERSEUS study results on tolebrutinib disappointing Study Results Multiple Sclerosis Sanofi Tolebrutinib PERSEUS Study
BRIEF published on 12/15/2025 at 07:10, 10 months 20 days ago Sanofi Halts Pursuit of Regulatory Registration for Tolebrutinib in PPMS Multiple Sclerosis Tolebrutinib PPMS Trial PERSEUS Study Sanofi R&D
BRIEF published on 12/15/2025 at 07:10, 10 months 20 days ago Sanofi renonce à l'autorisation de mise sur le marché du tolebrutinib dans le traitement de la SEP progressive primaire Sclérose En Plaques Tolebrutinib Essai PPMS Étude PERSEUS Recherche Et Développement Chez Sanofi
BRIEF published on 12/15/2025 at 07:10, 10 months 20 days ago Sanofi : résultats de l'étude PERSEUS sur le tolébrutinib décevants Sclérose En Plaques Sanofi Tolebrutinib Étude PERSEUS Résultats D'étude
BRIEF published on 12/15/2025 at 07:05, 10 months 20 days ago Sanofi's Tolebrutinib Regulatory Submission Delayed FDA Multiple Sclerosis Sanofi Tolebrutinib Regulatory Delay
Published on 11/04/2026 at 15:55, 3 hours 10 minutes ago Boba Mint Outlines Planned Heatcheck Rebrand and Asset Restructuring and Announces Cease Trade Order
Published on 11/04/2026 at 15:07, 3 hours 58 minutes ago Boron One Signs Second Binding Offtake Agreement for Sale of Boron Concentrates and Refined Boron Products
Published on 11/04/2026 at 15:00, 4 hours 5 minutes ago Vox Royalty Provides Update & Timeline for Assets Entering Production
Published on 11/04/2026 at 15:00, 4 hours 5 minutes ago ShelfieTech Announces Closing of Acquisition of Majority Interest in Aspect
Published on 11/04/2026 at 14:00, 5 hours 5 minutes ago Adcore to Publish Third Quarter 2026 Results on November 10, 2026
Published on 11/04/2026 at 18:43, 22 minutes ago EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 59 minutes ago Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
Published on 11/04/2026 at 17:40, 1 hour 25 minutes ago Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.10.26.
Published on 11/04/2026 at 17:30, 1 hour 34 minutes ago Kudelski Security Joins CrowdStrike Project QuiltWorks to Accelerate Remediation Against Frontier AI Risk
Published on 11/04/2026 at 17:30, 1 hour 34 minutes ago Artprice by Artmarket presents a liber mundi, dixit Gemini: 'Dialogue Between a Thinker and AI' carries within it the serene, yet profound, echo of the greatest anthropological shock of our era
Published on 11/04/2026 at 18:00, 1 hour 4 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 1 hour 4 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 1 hour 21 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
